Reporting

ASPR/CDC Mpox Vaccination Operational Planning Guide - HHS Mpox Vaccination Program

Data reporting requirements as outlined in the Data Use Agreements (DUAs) will remain in effect, including reporting on inventory and vaccine administration and is not impacted by the PHE declaration. Jurisdictions should continue providing weekly inventory and administration reporting as outlined below. Note, with this shift to thresholds, there is no longer a requirement to meet the 85% utilization before ordering vials against the threshold.

A vial can be considered used if any of the following apply:

A vial is opened, even if only a single shot is administered
A vial is reserved for second doses
The entire vial is unusable; in addition, the vial should be reported as wastage in HPOP

All other vials should count towards the jurisdiction’s available inventory, including vials that have been re-distributed beyond the site receiving direct shipment.

The following table displays which metrics should be captured in each reporting requirement.

**Mpox Reporting Requirements**
Reporting Requirement	Vials/Doses Administered	Vials Wasted	Vials Redistributed	Vials for 1st Doses	Vials for 2nd Doses
Administration (IIS or IZDL)	X (Doses)
Inventory (HPOP)	X (Vials)	X	X	X	X

Please make sure inventory data in HPOP is up to date and accurate.
Inventory data reported in HPOP should reflect,

All vials at sites that receive a direct shipment by site or re-distributed or aggregated by jurisdiction.
Inventory related to the 2022 mpox outbreak response (i.e., JYNNEOS vaccine received from the USG regardless of the phase during which it was ordered/received)
Inventory from the primary order site that remains on-hand
Inventory reported in vials
Please note: Inventory reporting is intended to capture the total inventory available for administration including vials for both first and second doses.

For ease of reference, the mpox vaccine inventory and wastage guidance is shown in the table below.

**Mpox Vaccine Inventory and Wastage Guidance**
Product Label	Authorization	Authorized For	Regimen	Vial Volume	Doses Per Vial	Max Reportable Inventory (Unopened Vials Only)	Max Reportable Wastage (Vials Only)
JYNNEOS	FDA Approved	18+ years	0.5 mL subcutaneous	0.5 mL	1	1	1
	EUA	<18 years	0.5 mL subcutaneous	0.5 mL	1	1	1
	EUA	18+ years	0.1 mL intradermal	0.5 mL	Up to 5	1	1

Please review the reporting specifications provided by CDC and contact the IZDL Help Desk (IZDLHelpDesk@cdc.gov) with questions. For both aggregate and line-level data submission, jurisdictions may opt to report weekly or each day. The deadline for weekly submission is 4 a.m. ET on Tuesdays for the previous Sunday through Saturday, unless notified by CDC that reporting on a specific holiday is not required.

Operational Planning Guide